Mundipharma presents additional results from global phase III ReSPECT trial of Rezzayo for prophylaxis of IFDs in adult patients undergoing allo-HSC at IDWeek 2026: Cambridge, UK ...

Mankind Pharma, India’s fourth largest pharmaceutical Company announced its financial results for the second quarter and half year ended 30th September 2026. The company's revenue from operations ...

Eris Lifesciences Limited, a leading Indian branded formulations manufacturing company, announced its earnings for the quarter and half year ended September 30, 2026. The company's consolidated ...

Innovent reports international phase 3 study of arcotatug tavatecan in gastric cancer meets dual primary endpoints of PFS and OS: San Francisco Monday, October 26, 2026, 17:00 Hrs ...

MAHE sets up advanced BSL-3 facility for high-containment biomedical research: Our Bureau, Bengaluru Monday, October 26, 2026, 16:30 Hrs [IST] Manipal Academy of Higher Education ...

DSS Takara Bio-supported breast-cancer R&D lays strong foundation for future advances in treatment: Our Bureau, Bengaluru Monday, October 26, 2026, 16:15 Hrs [IST] DSS Takara Bio ...

The WHO Global Traditional Medicine Centre is launching a series of working papers designed to document and examine traditional, complementary and integrative medicine (TCIM) worldwide. The inaugural ...

AIG Hospitals and Boston Scientific to set-up Centre of Excellence to strengthen access to therapeutic GI endoscopy: Our Bureau, Bengaluru Monday, October 26, 2026, 15:45 Hrs [IST ...

A precision T-cell therapy stalls treatment-resistant cancers in clinical trial: Bethesda, Maryland Monday, October 26, 2026, 15:00 Hrs [IST] Early results of the first clinical t ...

CSO raises concern over inclusion of Dr Naresh Trehan in Committee to review pharma marketing practices: Our Bureau, New Delhi Monday, October 26, 2026, 14:15 Hrs [IST] Raising co ...

African Medicines Agency and EMA issue joint guidance on Ebola vaccine development: Amsterdam, The Netherlands Monday, October 26, 2026, 14:00 Hrs [IST] EMA’s Emergency Task For ...

PHOSSCON focuses on 60% childhood cancer survival target by 2030: Our Bureau, Mumbai Monday, October 26, 2026, 13:45 Hrs [IST] India’s goal of achieving a childhood cancer survi ...